| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |